Articles Alert

CHEMISTRY BY RON MAGOLDA Medical Products Department E.I. du Pont de Nemours & Co. Wilmington, Del. " Strategies to control H1V-1 replication are being intensively investigated. A promising approach has been described using oligonucleoside phosphoramidates and phosphorothioates as antivitral agents. S. Argawal, J. Goodchild, M.P. Civeira, A.H. Thornton, P.S. Sam, P.C. Zamecnik, "Oligonucleoside phosphoramidates and phosphorothiostes as inhibitors of human immunodeficiency virus," Proceeding

Written byRon Magolda
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

BY RON MAGOLDA
Medical Products Department
E.I. du Pont de Nemours & Co.
Wilmington, Del.

" Strategies to control H1V-1 replication are being intensively investigated. A promising approach has been described using oligonucleoside phosphoramidates and phosphorothioates as antivitral agents.

S. Argawal, J. Goodchild, M.P. Civeira, A.H. Thornton, P.S. Sam, P.C. Zamecnik, "Oligonucleoside phosphoramidates and phosphorothiostes as inhibitors of human immunodeficiency virus," Proceedings of the National Academy of Sciences of the USA, 85 (19), 7079-83, October 1988.

" The design of specific synthetic receptors is of growing interest in bioorganic chemistry. A new paper reports how a synthetic receptor was designed to recognize and transport across a chloroform interface adenine derivatives.

T. Benzing, T. Tjivikua, J. Wolfe, J. Rebek, "Recognition and transport of adenine derivatives with synthetic receptors," Science, 242 (4876), 206-8, 14 October 1988.

" New synthetic methodology that affords facile preparation of polycyclic amines and ethers is of tremendous ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies